Bio

Stephanie Tang is a partner and Head of Private Equity in Greater China. She is based in Hong Kong. Stephanie is a well-regarded M&A (both public and private), private equity, and capital markets partner with a strong track record of successfully advising Chinese companies on their outbound investments and global private equity sponsors on their investments in Asia. In the M&A arena, Stephanie represents private equity firms and public and private companies in a variety of public and private cross-border transactions. Stephanie's transactional practice spans the range of M&A activity, including LBOs, take-private transactions, de-SPACs, equity investments, PIPEs, and other complex cross-border transactions. In recent years, Stephanie led 29 take-private transactions of U.S.-listed Chinese companies, many of these companies have achieved listing in Chinese A-share market subsequent to the privatization. In addition, she has represented both issuers and underwriters on New York Stock Exchange and NASDAQ IPOs, private placements of equity and equity-linked securities, and Rule 144A and Regulation S offerings by China-based companies. Stephanie has been listed as a “Highly regarded" lawyer for M&A and Private Equity by IFLR1000 in Hong Kong. For three consecutive years since 2020, Stephanie has been named as an “expert" in Private Equity by Euromoney’s Women in Business Law Expert Guide, 2020-2022. Stephanie was named “Female Dealmaker, North Asia" 2021 by Asian Legal Business. She also gained the Best M&A Legal Service Award 2017 – China Mergers & Acquisitions Association. Stephanie is a frequent writer and speaker on a range of topics affecting cross-border capital raising and M&A activities and co-authored the chapter, “Investing: China”, The Private Equity Review (Kirk August Radke, editor), 2013, 2014. Stephanie is regularly quoted in news articles by Reuters, Bloomberg, CNBC and Nikkei Asia on regulatory reform initiatives and market developments.